Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
批准号:
9236188
负责人:
Kameshwar P Singh
金额:
$34.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2018-03-31
关键词:
AddressAgeAgingAging-Related ProcessAllelesAnimal ModelAryl Hydrocarbon ReceptorBiologyBloodBone Marrow TransplantationCell AgingCell CycleCell physiologyCellular biologyChemicalsClinicalCritical PathwaysDNA DamageDataDevelopmentDiseaseEpigenetic ProcessEquilibriumEtiologyEventExposure toFailureFamilyGenerationsGeneticHealthHematologic NeoplasmsHematopoieticHematopoietic SystemHematopoietic stem cellsHumanHypoxiaImmune responseImmune systemIncidenceKnockout MiceLaboratoriesLeadLiteratureMalignant NeoplasmsMediatingMolecular BiologyOrganismPancytopeniaPathway AnalysisPathway interactionsPhenotypePhysiologicalPlayPremature aging syndromeProcessReactive Oxygen SpeciesReceptor SignalingRegulationRoleSignal PathwaySignal TransductionStressTechniquesTestingTherapeuticTissuesToxic effectWNT Signaling PathwayWorkXenobioticsbasecancer therapyleukemialeukemogenesismembernoveloxidative DNA damageoxidative damagepathogenpermissivenessprematurepublic health relevancereceptor expressionreceptor functionregenerativeresponseself-renewalsenescencestem cell biologystem cell populationstressortissue regenerationtranscription factor
中文摘要
描述(由申请人提供):造血干细胞(hsc)具有自我更新和分化为所有血液谱系的能力。静息、自我更新、增殖和分化之间的平衡被精确地维持,以在生物体的整个生命周期中,以及在对压力、组织损伤和病原体的反应中保持多谱系的产生。尽管造血干细胞中这些过程的失调对人类健康有着巨大的影响,但这种平衡是如何被调节的还不是很清楚。最近的数据支持了芳烃受体(AhR)是造血干细胞生理调节因子的新假设。这些数据支持了AhR通过抑制过度或不必要的增殖和促进HSC静止而起到负调节作用的观点。虽然我们的实验室已经做了很多工作来了解与HSC中AhR破坏相关的生物学,但我们还没有确定AhR调节的信号通路,这些信号通路定义了正常的HSC功能,以及在AhR失调的条件下在功能改变中发挥作用。我们假设Wnt和/或HIF信号通路对ahr介导的hsc调控至关重要。我们还假设造血干细胞中AhR表达的失调,通过破坏这些途径,导致氧化DNA损伤的积累,最终限制自我更新并导致过早衰老。结合分子和细胞生物学技术、独特的动物模型和信号通路分析,我们将确定HSC中AhR调节的信号通路,这些信号通路定义AhR功能,并且在失调的条件下可能导致HSC衰老和造血疾病。
英文摘要
DESCRIPTION (provided by applicant): Hematopoietic stem cells (HSCs) have the ability to self-renew and differentiate into all blood lineages. A balance among quiescence, self-renewal, proliferation, and differentiation is precisely maintained to preserve multi-lineage generation throughout the organism's lifetime, and during responses to stress, tissue damage, and pathogens. Although the dysregulation of these processes in HSCs has immense implications for human health, how this balance is regulated is not well understood. Recent data support the novel hypothesis that the aryl hydrocarbon receptor (AhR) is a physiological regulator of HSCs. These data support the contention that AhR acts as a negative regulator by curbing excessive or unnecessary proliferation and promoting HSC quiescence. While our lab has done much work to understand the biology associated with AhR disruption in HSCs, we have not yet identified AhR-regulated signaling pathways that define normal HSC function as well as play a role in altered function under conditions of AhR dysregulation. We hypothesize that the Wnt and/or HIF signaling pathways are critical for AhR-mediated regulation of HSCs. We also hypothesize that dysregulation of AhR expression in HSCs, through disruption of these pathways, results in accumulation of oxidative DNA damage that eventually restricts self-renewal and causes premature senescence. Using a combination of molecular and cell biology techniques, unique animal models, and signaling pathway analyses, we will determin AhR-regulated signaling pathways in HSCs that define AhR function and that may lead to, under conditions of dysregulation, to HSC senescence and hematopoietic disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Aryl Hydrocarbon Receptor and Stem Cells.
芳基烃受体和干细胞。
DOI:
10.1155/2017/4602854
发表时间:
2017
期刊:
Stem cells international
影响因子:
4.3
作者:
[Gasiewicz,ThomasA, Singh,KameshwarP, Casado,FannyL]
通讯作者:
Casado,FannyL
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:9026615
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2013
-
负责人:Kameshwar P Singh
-
依托单位:
Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells
-
批准号:8827772
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2013
-
负责人:Kameshwar P Singh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: